Related references
Note: Only part of the references are listed.Design of Substrate Transmembrane Mimetics as Structural Probes for γ-Secretase
Sanjay Bhattarai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
The substrate repertoire of γ-secretase/presenilin
Gokhan Guener et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Designed Helical Peptides as Functional Probes for γ-Secretase
Anijamol T. Philip et al.
BIOCHEMISTRY (2019)
Structural basis of Notch recognition by human γ-secretase
Guanghui Yang et al.
NATURE (2019)
Recognition of the amyloid precursor protein by human γ-secretase
Rui Zhou et al.
SCIENCE (2019)
Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease
Mikael Marttinen et al.
FRONTIERS IN NEUROSCIENCE (2018)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?
Matthew G. Bursavich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase
David M. Bolduc et al.
ELIFE (2016)
Emerging Concepts in Alzheimer's Disease
Harry V. Vinters
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
An atomic structure of human γ-secretase
Xiao-chen Bai et al.
NATURE (2015)
Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid β-Peptides (Aβ) by γ-Secretase to Increase 42-to-40-Residue Aβ
Marty A. Fernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Evidence of a Novel Mechanism for Partial γ-Secretase Inhibition Induced Paradoxical Increase in Secreted Amyloid β Protein
Eliza Barnwell et al.
PLOS ONE (2014)
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Naoko Takebe et al.
PHARMACOLOGY & THERAPEUTICS (2014)
γ-Secretase inhibitors and modulators
Todd E. Golde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43
Masayasu Okochi et al.
CELL REPORTS (2013)
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric et al.
ARCHIVES OF NEUROLOGY (2012)
BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity
Christina J. Crump et al.
BIOCHEMISTRY (2012)
The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
Lucia Chavez-Gutierrez et al.
EMBO JOURNAL (2012)
Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
Yasuyuki Mitani et al.
JOURNAL OF NEUROSCIENCE (2012)
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
Alix de Calignon et al.
NEURON (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Trans-Synaptic Spread of Tau Pathology In Vivo
Li Liu et al.
PLOS ONE (2012)
The Many Substrates of Presenilin/gamma-Secretase
Annakaisa Haapasalo et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor
Kevin W. Gillman et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment
Mako Takami et al.
JOURNAL OF NEUROSCIENCE (2009)
gamma-Secretase in biology and medicine
Michael S. Wolfe
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
The Role of Amyloid Precursor Protein Processing by BACE1, the β-Secretase, in Alzheimer Disease Pathophysiology
Sarah L. Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease
Scott C. Mayer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Aβ46 is processed to Aβ40 and Aβ43, but not to Aβ42, in the low density membrane domains
Sosuke Yagishita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, LY-450139
Thomas A. Lanz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway
Dragana Spasic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
γ-Secretase substrate selectivity can be modulated directly via interaction with a nucleotide-binding site
PC Fraering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
γ-cleavage is dependent on ζ-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain
GJ Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A nine-transmembrane domain topology for presenilin 1
H Laudon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The initial substrate-binding site of γ-secretase is located on presenilin near the active site
AY Kornilova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor
DM Barten et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Longer forms of amyloid β protein:: Implications for the mechanism of intramembrane cleavage by γ-secretase
Y Qi-Takahara et al.
JOURNAL OF NEUROSCIENCE (2005)
Probing pockets S2-S4′ of the γ-secretase active site with (hydroxyethyl)urea peptidomimeties
WP Esler et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
GT Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Purification and characterization of the human γ-secretase complex
PC Fraering et al.
BIOCHEMISTRY (2004)
Stereochemical analysis of (hydroxyethyl)urea peptidomimetic inhibitors of γ-secretase
P Bakshi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Discovery of a subnanomolar helical D-tridecapeptide inhibitor of γ-secretase
F Bihel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
γ-secretase:: proteasome of the membrane?
R Kopan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional γ-secretase inhibitor
GH Searfoss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Gleevec inhibits β-amyloid production but not Notch cleavage
WJ Netzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Designed helical peptides inhibit an intramembrane protease
C Das et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Potential link between amyloid β-protein 42 and C-terminal fragment γ 49-99 of β-amyloid precursor protein
T Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
γ-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2
WT Kimberly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Reconstitution of γ-secretase activity
D Edbauer et al.
NATURE CELL BIOLOGY (2003)
The role of presenilin cofactors in the γ-secretase complex
N Takasugi et al.
NATURE (2003)
Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate
WP Esler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with notch processing
A Weidemann et al.
BIOCHEMISTRY (2002)
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
HF Dovey et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment γ -: Evidence for distinct mechanisms involved in γ-secretase processing or the APP and Notch1 transmembrane domains
CJ Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
S Weggen et al.
NATURE (2001)
Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch
YJ Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Presenilin dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch
M Sastre et al.
EMBO REPORTS (2001)
Difluoro ketone peptidomimetics suggest a large S1 pocket for Alzheimer's γ-secretase:: Implications for inhibitor design
CL Moore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity
MS Shearman et al.
BIOCHEMISTRY (2000)
Presenilins are required for γ-secretase cleavage of β-APP and transmembrane cleavage of Notch-1
ZH Zhang et al.
NATURE CELL BIOLOGY (2000)
Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells
A Herreman et al.
NATURE CELL BIOLOGY (2000)
Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
WP Esler et al.
NATURE CELL BIOLOGY (2000)
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
YM Li et al.
NATURE (2000)
Share Paper
